|
NOTE
6 - FINANCING EXPENSES, NET
SCHEDULE OF FINANCING EXPENSES
| |
|
2021 |
|
|
2020 |
|
| |
|
Six months period ended June 30,
|
|
| |
|
2021 |
|
|
2020 |
|
| |
|
|
|
|
|
|
| Modification of terms relating to straight loan transaction |
|
$ |
88 |
|
|
$ |
- |
|
| Modification of terms relating to convertible bridge loans transactions |
|
|
- |
|
|
|
3,839 |
|
| Exchange differences relating to loans from shareholders |
|
|
- |
|
|
|
83 |
|
| Issuance of shares as a settlement in excess of the carrying amount of financial liabilities |
|
|
- |
|
|
|
499 |
|
| Amortization of discounts and accrued interest on convertible bridge loans |
|
|
13,648 |
|
|
|
(2,503 |
) |
| Amortization of discounts and accrued interest on straight loans |
|
|
653 |
|
|
|
80 |
|
| Change in fair value of derivative warrants liability and fair value of warrants expired |
|
|
(294 |
) |
|
|
- |
|
| Change in fair value of liability related to conversion feature of convertible bridge loans |
|
|
(4,307 |
) |
|
|
(120 |
) |
| Issuance of shares as call options to acquire potential acquire |
|
|
- |
|
|
|
2,000 |
|
| Settlement in cash of prepayment obligation related to convertible bridge loan |
|
|
182 |
|
|
|
- |
|
| Interest and related royalties under receivables financing facility |
|
|
311 |
|
|
|
- |
|
| Amortization of prepaid expenses related to commitment shares in connection with receivables financing facility and equity line |
|
|
293 |
|
|
|
- |
|
| Exchange rate differences and other finance expenses |
|
|
(89 |
) |
|
|
442 |
|
| Financing (income) expenses, net |
|
$ |
10,485 |
|
|
$ |
4,320 |
|
TODOS
MEDICAL LTD.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
(U.S.
dollars in thousands)
|